What is Disc Medicine's D&A?

Disc Medicine (IRON) reported D&A of $89K in Q1 2026.

How has Disc Medicine's D&A changed year-over-year?

Disc Medicine's D&A increased by 345.0% year-over-year, from $20K to $89K.

What is the long-term trend for Disc Medicine's D&A?

Over 3 years (2022 to 2025), Disc Medicine's D&A has grown at a 46.7% compound annual growth rate (CAGR), from $89K to $281K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Disc Medicine IRON D&A

D&A at other companies

Bristol-Myers SquibbBMY

$594M-41.3%

Vertex PharmaceuticalsVRTX

$55.9M+15.5%

Protagonist TherapeuticsPTGX

$407K+70.3%

Agios PharmaceuticalsAGIO

$1.36M+6.7%

Beam TherapeuticsBEAM

$5.61M+1.4%

Travere Therapeutics, Inc.TVTX

$25.21M+96.9%

Other financials

Income statement

See full

Operating income-$69.5M-74.0%

Net income-$63.5M-86.3%

EPS (diluted)-$1.65-61.8%

Balance sheet

See full

Cash & equivalents$88.9M-27.5%

Total debt$31.1M+1.4%

Total equity$688.4M+4.3%

Total assets$750.2M+5.8%

Cash flow

See full

Operating cash flow-$62.2M-50.4%

CapEx--100%

Free cash flow-$62.2M-47.4%

Valuation

See full

Market cap$2.69B+42.2%

Enterprise value$2.63B+46.7%

Returns & leverage

See full

Return on equity-35.8%+41.3pp

Debt / equity0×0.0×

Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Disc Medicine's D&A?: Disc Medicine (IRON) reported D&A of $89K in Q1 2026.
How has Disc Medicine's D&A changed year-over-year?: Disc Medicine's D&A increased by 345.0% year-over-year, from $20K to $89K.
What is the long-term trend for Disc Medicine's D&A?: Over 3 years (2022 to 2025), Disc Medicine's D&A has grown at a 46.7% compound annual growth rate (CAGR), from $89K to $281K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.